ESR2 and breast neoplasm: To investigate whether loss of ERβ synergizes with p53 inactivation to promote early onset of breast tumors, we introduced the ERβF allele into the K14Crep53F/F model to generate K14CreERβF/Fp53F/F and K14CreERβF/+p53F/F female mice.